SecSonar.com

Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Puma Biotechnology, Inc. (PBYI) is a Biotechnology company based in US with a market capitalization of $364.7M. Revenue declined 0.9% year-over-year and the company generated $41.7M in free cash flow. This page tracks PBYI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 172 employees · IPO Apr 24, 2012

Valuation

Valuation & price

$6.92 · as of May 17, 2026 · -16.2% vs 52w high

11.3

P/E ratio

Latest-FY diluted EPS

2.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.26$5.68$3.11Jul 25Dec 25Jul 26Jul 7, 25$3.54Jul 9, 25$3.60Jul 11, 25$3.39Jul 15, 25$3.46Jul 17, 25$3.36Jul 21, 25$3.41Jul 23, 25$3.45Jul 25, 25$3.28Jul 29, 25$3.18Jul 31, 25$3.11Aug 4, 25$3.18Aug 6, 25$3.25Aug 11, 25$4.85Aug 13, 25$5.30Aug 15, 25$5.73Aug 19, 25$5.09Aug 21, 25$5.22Aug 25, 25$4.99Aug 27, 25$5.10Aug 29, 25$5.04Sep 3, 25$5.13Sep 5, 25$5.03Sep 9, 25$4.71Sep 11, 25$4.50Sep 16, 25$4.52Sep 18, 25$4.52Sep 22, 25$4.46Sep 24, 25$4.72Sep 26, 25$4.84Sep 30, 25$5.31Oct 2, 25$5.22Oct 6, 25$5.03Oct 8, 25$5.23Oct 10, 25$5.12Oct 14, 25$5.31Oct 16, 25$5.41Oct 21, 25$5.17Oct 23, 25$5.04Oct 27, 25$5.27Oct 29, 25$5.16Oct 31, 25$5.10Nov 4, 25$4.90Nov 6, 25$4.90Nov 10, 25$4.73Nov 12, 25$4.99Nov 14, 25$4.89Nov 18, 25$5.06Nov 20, 25$4.84Nov 25, 25$4.95Nov 28, 25$5.05Dec 2, 25$4.87Dec 4, 25$5.29Dec 8, 25$5.40Dec 10, 25$5.59Dec 12, 25$5.86Dec 16, 25$5.67Dec 18, 25$5.62Dec 22, 25$5.83Dec 24, 25$5.96Dec 29, 25$6.09Jan 2, 26$5.77Jan 6, 26$5.86Jan 8, 26$6.20Jan 12, 26$6.28Jan 14, 26$6.42Jan 16, 26$6.37Jan 21, 26$6.89Jan 23, 26$6.42Jan 27, 26$6.57Jan 29, 26$6.43Feb 2, 26$6.82Feb 4, 26$7.10Feb 9, 26$6.88Feb 11, 26$6.64Feb 13, 26$6.82Feb 18, 26$6.68Feb 20, 26$6.83Feb 24, 26$7.49Feb 26, 26$7.60Mar 2, 26$6.42Mar 4, 26$6.40Mar 6, 26$6.05Mar 10, 26$6.06Mar 12, 26$5.88Mar 17, 26$6.14Mar 19, 26$6.15Mar 23, 26$6.25Mar 25, 26$6.33Mar 27, 26$6.08Mar 31, 26$6.39Apr 2, 26$6.90Apr 7, 26$6.97Apr 9, 26$7.80Apr 13, 26$7.57Apr 15, 26$7.48Apr 17, 26$7.47Apr 22, 26$7.43Apr 24, 26$7.54Apr 28, 26$7.54Apr 30, 26$7.51May 4, 26$7.53May 6, 26$7.45May 8, 26$7.49May 12, 26$7.08May 14, 26$7.19May 18, 26$6.81May 20, 26$6.99May 22, 26$7.08May 28, 26$7.24Jun 1, 26$7.12Jun 3, 26$6.81Jun 5, 26$7.03Jun 9, 26$7.05Jun 11, 26$7.23Jun 15, 26$7.07Jun 17, 26$7.23Jun 22, 26$7.66Jun 24, 26$7.95Jun 26, 26$8.11Jul 2, 26$8.26
$3.0752-week range$8.26
Loading valuation history…

Fundamentals

Key fundamentals

$364.7M

Market cap

-0.9%

Revenue growth (YoY)

74.5%

Gross margin

$41.7M

Free cash flow (USD)

-$69M

Net debt

Net cash position

2.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$27.7MFY 2018$251.0MFY 2019$272.3MFY 2020$225.1MFY 2021$253.2MFY 2022$228.0MFY 2023$235.6MFY 2024$230.5MFY 2025$228.4M
$0$228.4M

Free cash flow by year

2016 → 2025

FY 2016$-149.0MFY 2017$-222.9MFY 2018$-24.7MFY 2019$22.1MFY 2020$-19.2MFY 2021$20.6MFY 2022$-22.8MFY 2023$14.4MFY 2024$38.9MFY 2025$41.7M
-$149M$41.7M

Gross margin by year

2021 → 2025

FY 202174.8%FY 202275.8%FY 202373.4%FY 202472.1%FY 202574.5%
74.8%74.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 16, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Puma Biotechnology, Inc.'s market cap?

Puma Biotechnology, Inc. (PBYI) has a market capitalization of $364.7M.

What is PBYI's P/E ratio?

PBYI trades at a price-to-earnings ratio of 11.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PBYI's price-to-book (P/B) ratio?

PBYI trades at 2.80 times book value per share.

Are insiders buying PBYI stock?

SEC Form 4 filings show no open-market insider buys at Puma Biotechnology, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

IRD

Opus Genetics, Inc.

$364.7M

RGNX

REGENXBIO Inc.

$365.2M

PALI

Palisade Bio, Inc.

$366.3M

KROS

Keros Therapeutics, Inc.

$361.9M

CCCC

C4 Therapeutics, Inc.

$367.8M

PTN

Palatin Technologies, Inc.

$368M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.